6,841,250 Shares of Common Stock and Pre-Funded Warrants to Purchase 2,158,750 Shares of Common Stock IDERA PHARMACEUTICALS, INC. PURCHASE AGREEMENTPurchase Agreement • February 5th, 2014 • Idera Pharmaceuticals, Inc. • Biological products, (no disgnostic substances) • New York
Idera Pharmaceuticals, Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of (i) 6,841,250 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.001 per share (the “Common Stock”), of the Company and (ii) warrants of the Company, in the form set forth in Exhibit C hereto, to purchase up to an aggregate of 2,158,750 shares of Common Stock at an exercise price of $0.01 per share (the “Pre-Funded Warrants”). The Company has also granted to the several Underwriters an option to purchase up to an aggregate of 1,026,188 additional shares of common stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares, the Pre-Funded Warrants and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”
